TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5856$ +1.8% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Humacyte Inc (HUMA): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/10/2026.

Next report 08/10/2026
Last report 08/12/2026
Earnings surprise by quarter (%)
Q3 23 · 4.0 % 23 Q4 23 · 0.0 % 23 Q1 24 · -8.7 % 24 Q2 24 · -100.0 % 24 Q3 24 · -8.3 % 24 Q4 24 · 18.0 % 24 Q1 25 · 233.3 % 25 Q2 25 · -33.3 % 25 Q3 25 · 26.7 % 25 Q4 25 · -46.4 % 25 Q1 26 · 18.2 % 26 Q2 26 · -60.0 % 26

EPS estimate beaten

Full history 10 of 23 quarters (43%)
Last 16 quarters 7 of 16 quarters (44%)

Earnings Call Transcripts

Search all transcripts →

  • 08/12/2026 Earnings Call Q2 2026 Open →
  • 05/13/2026 Earnings Call Q1 2026 Open →
  • 11/12/2025 Earnings Call Q3 2025 Open →
  • 08/11/2025 Earnings Call Q2 2025 Open →

News on This Stock

  • 08/12/2026 Humacyte, Inc. (HUMA): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/31/2026 Humacyte, Inc. (HUMA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?